PVMCV
Polaris Venture Management Co V Portfolio holdings
AUM
$14.1M
This Quarter Return
+3.37%
1 Year Return
+121.41%
3 Year Return
+278.88%
5 Year Return
+1,121.38%
10 Year Return
–
AUM
$224M
AUM Growth
+$224M
(+0.18%)
Cap. Flow
+$48.8M
Cap. Flow
% of AUM
21.75%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
2
Increased
–
Reduced
3
Closed
–
Top Buys
| 1 |
Pulmatrix
PULM
|
$34.6M |
| 2 |
ATYR
aTyr Pharma
ATYR
|
$33.9M |
Top Sells
| 1 |
Ocular Therapeutix
OCUL
|
$16.8M |
| 2 |
TTOO
T2 Biosystems, Inc
TTOO
|
$1.7M |
| 3 |
GNCA
Genocea Biosciences, Inc.
GNCA
|
$1.19M |
Sector Composition
| 1 | Healthcare | 78.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TTOO
1
DELISTED
T2 Biosystems, Inc
TTOO
| $36.8M | 16.43% |
2,269,578
-104,993
| -4% | -$1.7M |
|
|
2
Pulmatrix
PULM
$18M
| $34.6M | 15.45% |
+3,607,996
| New | +$34.6M |
|
|
ATYR
3
aTyr Pharma
ATYR
$527M
| $33.9M | 15.1% |
+1,827,992
| New | +$33.9M |
|
|
GNCA
4
DELISTED
Genocea Biosciences, Inc.
GNCA
| $27M | 12.05% |
1,968,606
-86,624
| -4% | -$1.19M |
|
|
5
Ocular Therapeutix
OCUL
$2.12B
| $25.9M | 11.54% |
1,230,009
-800,000
| -39% | -$16.8M |
|
|
TRVN
6
DELISTED
Trevena, Inc.
TRVN
| $23.6M | 10.52% |
3,769,280
| – | – |
|
7
Fate Therapeutics
FATE
$120M
| $16M | 7.14% |
2,473,186
| – | – |
|
8
Dare Bioscience
DARE
$27.2M
| $15.1M | 6.74% |
3,287,529
| – | – |
|
|
BIND
9
DELISTED
BIND THERAPEUTICS INC
BIND
| $11.3M | 5.03% |
2,018,253
| – | – |
|